glp 1 drugs for weight loss cost How do prices of in the U.S. compare to peer nations' prices? Perspectives from Employers on the
Description
Metseras pipeline includes MET-097i, a GLP-1 receptor agonist designed for once-monthly dosing, and MET-233i, an amylin analog being developed for monthly administration

22, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute medical advice

Schedule a consultation today!

See how GLP-1s are reshaping diabetes & obesity care.

Oral GLP-1 RA are also under development and early data shows similar WL efficacy to semaglutide 2.4mg
The European Cardiovascular Health Plan Roadmap from the European Alliance was published earlier in 2025 and calls for comprehensive approaches to incorporate the recognition of obesity as a trigger for cardiovascular disease
